Cite
Adhesion Reduction Agent Guardix-SG ® Versus MegaShield ® for Postoperative Swallowing Function Analysis in Thyroidectomy Patients.
MLA
Lee, Hye Kyoung, et al. “Adhesion Reduction Agent Guardix-SG ® Versus MegaShield ® for Postoperative Swallowing Function Analysis in Thyroidectomy Patients.” Clinical Medicine Insights: Oncology, Nov. 2024, pp. 1–18. EBSCOhost, https://doi.org/10.1177/11795549241271715.
APA
Lee, H. K., Hwang, J., Jo, S., Kim, J. K., Lee, C. R., Kang, S.-W., Nam, K.-H., & Cho, S.-R. (2024). Adhesion Reduction Agent Guardix-SG ® Versus MegaShield ® for Postoperative Swallowing Function Analysis in Thyroidectomy Patients. Clinical Medicine Insights: Oncology, 1–18. https://doi.org/10.1177/11795549241271715
Chicago
Lee, Hye Kyoung, Jihye Hwang, Seongmoon Jo, Jin Kyong Kim, Cho Rok Lee, Sang-Wook Kang, Kee-Hyun Nam, and Sung-Rae Cho. 2024. “Adhesion Reduction Agent Guardix-SG ® Versus MegaShield ® for Postoperative Swallowing Function Analysis in Thyroidectomy Patients.” Clinical Medicine Insights: Oncology, November, 1–18. doi:10.1177/11795549241271715.